Maynard Um
-
-
-
-
-
-
-
Guggenheim Reiterates Buy Rating on Bruker (BRKR)
-
-
-
-
-
-
-
Bruker launches spatial biology platforms and cross-platform workflows
-
-
-
-
-
-
-
Bruker launches CellScape XR proteomics platform, opens PaintScape pre-orders
-
-
-
-
-
-
-
Bruker secures $25 million in European magnetic resonance system orders
-
-
-
-
-
-
-
Nephron Upgrades Bruker (BRKR) to Hold
-
-
-
-
-
-
-
Bruker (BRKR) PT Lowered to $40 at TD Cowen Amid 'Tough Demand Environment'
-
-
-
-
-
-
-
Stifel Reiterates Hold Rating on Bruker (BRKR)
-
457,062 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

